Related Experiment Video
Updated: Sep 21, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Viral exploitation of p300/CBP at the virus-cancer interface: Chromatin regulation, oncogenesis, immune evasion, and
Ali M Atoom1, Jasur Rizaev2, Djamila Polatova3
1Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
Abstract:
The transcriptional coactivators p300 and CREB-binding protein (CBP) integrate chromatin remodeling, enhancer activity, lysine acetylation, immune signaling, and tumor-suppressor control, making them recurrent targets of viral proteins. This narrative review examines p300/CBP at the virus-cancer interface, prioritizing HTLV-1, high-risk HPV, EBV, KSHV, HBV, and HCV. We distinguish physical interaction, biochemical modulation, functional reliance, and therapeutic confirmation and compare how viral factors recruit, inhibit, degrade, or redistribute these coactivators during persistence, immune evasion, and malignant progression. Evidence from non-oncogenic viruses is retained only when it clarifies conserved mechanisms or therapeutic liabilities. Preclinical studies support catalytic, interaction-selective, and virus-specific targeting strategies, but human evidence is limited to early-phase PRI-724/OP-724 antifibrotic studies in viral cirrhosis. Because p300/CBP also support normal transcription and antiviral immunity, systemic inhibition may cause substantial toxicity. Overall, p300/CBP are best viewed as context-dependent regulatory hubs, and translation will require paralog-, domain-, and disease-specific validation.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
